Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
- Resource Type
- Correction Notice
- Source
Journal of Experimental & Clinical Cancer Research (17569966) . 4/11/2022, Vol. 41 Issue 1, p1-4. 4p.- Subject
- *
CANCER stem cells
*CANCER chemotherapy
*PANCREATIC cancer
*PANCREATIC intraepithelial neoplasia
*BORTEZOMIB
*PANCREATIC tumors - Language
- ISSN
- 1756-9966